Real-time enrollment status for this symptomatic non-erosive gastroesophageal reflux disease clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 10:32 AM UTC
| NCT Number | NCT07752407 |
| Recruiting Status | Recruiting |
| Condition | Symptomatic Non-erosive Gastroesophageal Reflux Disease |
| Phase | PHASE3 |
| Target Enrollment | 500 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Phathom Pharmaceuticals, Inc. |
| Last Updated on CT.gov | October 7, 2026 (1 week ago) |
As of October 15, 2026: Clinical trial NCT07752407 is currently recruiting participants. This phase3 study for symptomatic non-erosive gastroesophageal reflux disease is actively seeking new participants at 1 location across the United States. The study is sponsored by Phathom Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07752407 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07752407 was last updated 1 week ago (October 7, 2026). HelloStudys verifies this status automatically.